Philip G Conaghan

Philip G Conaghan

UNVERIFIED PROFILE

Are you Philip G Conaghan?   Register this Author

Register author
Philip G Conaghan

Philip G Conaghan

Publications by authors named "Philip G Conaghan"

Are you Philip G Conaghan?   Register this Author

100Publications

1830Reads

34Profile Views

Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.

Adv Ther 2019 Jun 9;36(6):1398-1411. Epub 2019 Apr 9.

Flexion Therapeutics, Inc, 10 Mall Road, Suite 301, Burlington, MA, 01803, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-019-00944-3DOI Listing
June 2019

Therapeutic options for targeting inflammatory osteoarthritis pain.

Nat Rev Rheumatol 2019 Jun;15(6):355-363

Department of Clinical Immunology & Rheumatology, Academic Medical Centre, Amsterdam University Medical Centre, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41584-019-0221-y
Publisher Site
http://dx.doi.org/10.1038/s41584-019-0221-yDOI Listing
June 2019

Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis.

Rheumatology (Oxford) 2019 May 12. Epub 2019 May 12.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez162DOI Listing
May 2019

Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group.

J Rheumatol 2019 May 15. Epub 2019 May 15.

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. This work was supported by a grant from Association Française de Lutte Anti Rhumatisme - France Rhumatisme (France) and the Kolling Foundation (Australia). This work was endorsed by OMERACT and Osteoarthritis Research Society International and by the STPR Group in Rheumatology in France. PGC is supported in part by the UK NIHR Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. GH receives salary support as the Sir John and Lady Eaton Professor and Chair of Medicine at the University of Toronto. F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital. Address correspondence to Dr. F. Guillemin, EA 4360 APEMAC, School of Public Health - BP 20999, 54500 Vandoeuvre-les-Nancy, France. E-mail: Accepted for publication March 7, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181085DOI Listing
May 2019

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.

J Rheumatol 2019 Apr 1. Epub 2019 Apr 1.

From the Department of Epidemiology and Biostatistics, Amsterdam University Medical Centre (VUmc); VUmc, Department of Medical Humanities, Amsterdam Public Health (APH), Amsterdam; Department of General Practice, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; Comprehensive Pain Center, University Hospital Carl Gustav Carus Dresden, Medical Faculty of the Technical University Dresden, Dresden, Germany; CREATE Centre, Section of Rheumatology, Division of Infection and Immunity, Cardiff University, Cardiff; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds; Versus Arthritis, Patron Her Royal Highness The Duchess of Cornwall, Chesterfield; MRC North West Hub for Trials Methodology Research, Department of Biostatistics, University of Liverpool, Liverpool, UK; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; The Rheumatology Research Unit, Department of Rheumatology, Odense University Hospital; Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark; Dragon Claw (Website for patients with rheumatic disease), New South Wales, Australia; Bingo and Fundraising Promotions, Mal Atwell Leisure Group, Willetton, Australia; SDG LLC, Cambridge, Massachusetts; Medicine Service, VA Medical Center; Departments of Medicine and Epidemiology at the Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Department of Anesthesiology and Pain Medicine, University of Washington; Rheumatology Research Swedish-Providence-St. Joseph Health Systems; University of Washington School of Medicine, Seattle, Washington, USA; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. AC is supported by a postdoctoral fellowship of the Amsterdam Movement Sciences research institute; he was supported by OMERACT and by a European League Against Rheumatism bursary to attend the OMERACT 2018 conference. UK is funded by a postdoctoral fellowship of the Medical Faculty, Technical University Dresden, and also funded by a federal joint committee of Germany. EC is supported in part by Arthritis Research UK and Health and Care Research Wales through the CREATE Centre. The Parker Institute, Bispebjerg and Frederiksberg Hospital is supported by a core grant from the Oak Foundation (OCAY-13-309). PGC is supported in part by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. DCT is supported by the US National Institutes of Health (NIH) and the US Food and Drug Administration. EC has received research grants and/or served as member of advisory boards and speaker bureaus of AbbVie, Allergan, Amgen, AstraZeneca, Bio-Cancer, Biogen, BMS, Boehringer Ingelheim, Celgene, Chugai Pharma, Daiichi Sankyo, Eli Lilly, Ferring Pharmaceutical, GSK, Hospira, ISIS, Jazz Pharmaceuticals, Janssen, MedImmune, Merrimack Pharmaceutical, MSD, Napp, Novimmune, Novartis, ObsEva, Pfizer, Regeneron, Roche, R-Pharm, Sanofi, SynAct Pharma, Synovate, Tonix, and UCB. JAS has received consultant fees from Crealta/Horizon, Fidia, UBM LLC, Medscape, WebMD, the NIH, and the American College of Rheumatology. JAS is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JAS served as a member of the American College of Rheumatology's (ACR) Annual Meeting Planning Committee and Quality of Care Committees, the Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee and the co-chair of the ACR Criteria and Response Criteria subcommittee. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies. DCT is the editor-in-chief of The Clinical Journal of Pain and serves as an industry advisor or consultant to AcelRx, GSK/Novartis, and Pfizer. A. Chiarotto, PhD, Postdoctoral Research Fellow, Department of Epidemiology and Biostatistics, VUmc, and Department of General Practice, Erasmus MC, University Medical Center Rotterdam; U. Kaiser, Dr. Rer. Nat., Postdoctoral Research Fellow and Principal Investigator, Comprehensive Pain Center, Medical Faculty of Technical University of Dresden; E. Choy, MD, Professor and Head of Rheumatology, Cardiff University; R. Christensen, PhD, Professor of Biostatistics and Clinical Epidemiology, The Rheumatology Research Unit, Department of Rheumatology, Odense University Hospital and University of Southern Denmark, and Head of Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; P.G. Conaghan, MB BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; M. Cowern, OMERACT Patient Research Partner; M. Gill, BA, Australian National University, and Dragon Claw, and OMERACT Patient Research Partner; M. de Wit, PhD, OMERACT Patient Research Partner, and Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health; E. Gargon, PhD, Research Associate, Department of Biostatistics, University of Liverpool; B. Horgan, OMERACT Patient Research Partner; J.J. Kirkham, PhD, Senior Lecturer in Medical Statistics, Department of Biostatistics, University of Liverpool; L.S. Simon, MD, Principal, SDG LLC; J.A. Singh, MBBS, MPH, Endowed Professor of Medicine, University of Alabama at Birmingham; P. Tugwell, MD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; D.C. Turk, PhD, John and Emma Bonica Endowed Chair and Professor of Anesthesiology and Pain Research, Department of Anesthesiology and Pain Medicine, University of Washington; P.J. Mease, MD, MACR, Director, Rheumatology Research, Swedish-Providence-St. Joseph Health Systems, and Clinical Professor, University of Washington School of Medicine. Address correspondence to Dr. A. Chiarotto, Department of Epidemiology and Biostatistics, Amsterdam Movement Sciences Research Institute, Amsterdam Public Health Research Institute, Amsterdam UMC (VU University Medical Center), Medical Faculty, F-vleugel, de Boelelaan 1089A, 1081HV Amsterdam, the Netherlands. E-mail: Accepted for publication March 8, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181099DOI Listing
April 2019

Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?

Drugs Aging 2019 04;36(Suppl 1):7-14

Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40266-019-00658-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509082PMC
April 2019

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017.

J Rheumatol 2019 Mar 1. Epub 2019 Mar 1.

From the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford; School of Health and Social Care, London South Bank University, London; Institute of Translational Medicine, University of Liverpool, Liverpool; Faculty of Health and Medical Sciences, University of Surrey, Guildford; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC), Leeds, UK; Department of Medicine, Faculty of Medicine, and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Institute of Bone and Joint Research, Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital, Sydney, Australia; Department of Epidemiology and Biostatistics, Amsterdam University Medical Centres, location VUmc; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health, Amsterdam; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands; Musculoskeletal Statistics Unit, the Parker Institute, Bispebjerg and Frederiksberg Hospital and Department of Rheumatology, Odense University Hospital; Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark; Université de Lorraine, APEMAC, Nancy, France; Division of Rheumatology, Allergy and Immunology, Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina; Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago; Sections of Clinical Epidemiology and Rheumatology, Boston University School of Medicine, Boston; TissueGene Inc., Rockville; Division of Rheumatology and Clinical Immunology, Department of Medicine and Division of Gerontology, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA; Merck Biopharma, Merck KGaA, Darmstadt; University Pain Centre, University Hospital Carl Gustav Carus, Dresden, Germany; Inner West Psychology; Institute of Bone and Joint Research, Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital; School of Biological, Earth and Environmental Sciences, University of New South Wales, Sydney, Australia; Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania; Faculty of Humanities and Social Sciences, University of Lucerne, Lucerne, Switzerland. Research for this article was supported by the NIHR Oxford BRC (T.O. Smith) and the Leeds BRC (Prof. P.G. Conaghan). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health. C.H. Ladel is an employee of Merck Biopharma, Merck KgaA, and Dr. G. Kalsi is an employee of TissueGene Inc. T.O. Smith, PhD, Senior Researcher in Rehabilitation, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, and NIHR Oxford BRC, John Radcliffe Hospital, Oxford; M. Mansfield, MSc, Senior Lecturer in Physiotherapy, School of Health and Social Care, London South Bank University; G.A. Hawker, PhD, Professor of Medicine, Department of Medicine, Faculty of Medicine, and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto; D.J. Hunter, PhD, Florance and Cope Chair of Rheumatology Chair of Institute of Bone and Joint Research Professor of Medicine, Institute of Bone and Joint Research, Florance and Cope and Professorial Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital; L.M. March, PhD, Liggins Professor of Rheumatology and Musculosketal Epidemiology Medicine, Institute of Bone and Joint Research, Florance and Cope Professorial Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital; M. Boers, PhD, Professor of Clinical Epidemiology, Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers; B.J. Shea, PhD, Adjunct Professor, Ottawa Hospital Research Institute; R. Christensen, PhD, Professor of Biostatistics and Clinical Epidemiology, Musculoskeletal Statistics Unit, the Parker Institute, Bispebjerg and Frederiksberg Hospital and Department of Rheumatology, Odense University Hospital; F. Guillemin, PhD, Professor of Epidemiology and Public Health, Université de Lorraine, APEMAC; C.B. Terwee, PhD, Associate Professor in Clinimetrics, Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers; P.R. Williamson, PhD, Professor of Medical Statistics, Institute of Translational Medicine, University of Liverpool; E.M. Roos, PhD, Professor, Head of Research Unit, Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark; R.F. Loeser, MD, Herman and Louise Smith Distinguished Professor of Medicine, Division of Rheumatology, Allergy and Immunology, and Division of Rheumatology, Allergy and Immunology, Thurston Arthritis Research Center, University of North Carolina; T.J. Schnitzer, PhD, Professor of Physical Medicine and Rehabilitation, Anesthesiology and Medicine (Rheumatology), and Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine; M. Kloppenburg, PhD, Professor in Rheumatology, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Centre; T. Neogi, PhD, Professor, Epidemiology, Sections of Clinical Epidemiology and Rheumatology, Boston University School of Medicine; C.H. Ladel, PhD, Clinical Biomarker and Diagnostics Lead, Merck Biopharma, Merck KGaA; G. Kalsi, MD, Chief Medical Officer, Senior Vice President of Clinical Development and Regulatory and Medical Affairs, TissueGene Inc.; U. Kaiser, PhD, Principal Investigator, University Pain Centre, University Hospital Carl Gustav Carus; T.W. Buttel, MA, Psychologist, Inner West Psychology, and Institute of Bone and Joint Research, Florance and Cope Professorial Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital; A.E. Ashford, PhD, Emeritus Professor, School of Biological, Earth and Environmental Sciences, University of New South Wales; A. Mobasheri, DPhil, Professor of Musculoskeletal Physiology, Faculty of Health and Medical Sciences, University of Surrey, and Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine; N.K. Arden, MD, Professor in Rheumatic Diseases, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; A. Tennant, PhD, Permanent Visiting Professor, Faculty of Humanities and Social Sciences, University of Lucerne; M.C. Hochberg, MD, Professor of Medicine and Epidemiology and Public Health, Division of Rheumatology and Clinical Immunology, Department of Medicine, and Division of Gerontology, Department of Epidemiology and Public Health, University of Maryland School of Medicine; M. de Wit, PhD, Visiting Fellow, Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health; P. Tugwell, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; P.G. Conaghan, PhD, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds BRC. Address correspondence to Professor P.G. Conaghan, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS4 7SA, UK. E-mail: Accepted for publication December 3, 2018.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181066
Publisher Site
http://dx.doi.org/10.3899/jrheum.181066DOI Listing
March 2019

Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.

Arthritis Care Res (Hoboken) 2019 Mar 15. Epub 2019 Mar 15.

University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23873DOI Listing
March 2019

The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example.

J Rheumatol 2019 Mar 15. Epub 2019 Mar 15.

From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D'Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D'Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: Accepted for publication January 31, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181158DOI Listing
March 2019

The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders.

J Rheumatol 2019 Feb 1. Epub 2019 Feb 1.

From the Department of Rheumatology, Leiden University Medical Center, Leiden; Zuyderland Medical Center, Heerlen; Department of Psychology, Health and Technology, University of Twente, Enschede; Department of General Practice, Erasmus University Medical Center, Rotterdam, the Netherlands; School of Public Health and Preventive Medicine, Monash University; Monash Department of Physiotherapy, School of Primary and Allied Health Care, Monash University; Monash Department of Clinical Epidemiology, Cabrini Institute; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne; Department of Rheumatology, The Queen Elizabeth Hospital and the University of Adelaide; Adelaide Medical School, The University of Adelaide, Adelaide; University of Technology; Royal Prince Alfred Hospital, Camperdown NSW; University of Sydney, Sydney, Australia; Department of Orthopaedic Surgery, University of Michigan; Department of Epidemiology, School of Public Health, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan; Departments of Physical Medicine and Rehabilitation, Orthopaedics, and Epidemiology (Medicine), Vanderbilt University Medical Center, Nashville, Tennessee, USA; Institute for Work & Health; University of Toronto, Toronto; Ottawa Hospital Research Institute, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; University of Bristol, Bristol; Arthritis Research UK Primary Care Centre, Institute for Primary Care and Health Sciences, Keele University, Keele; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals UK National Health Service (NHS) Trust, Leeds; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Applied Health Sciences, Hochschule für Gesundheit Bochum (University of Applied Sciences), Bochum, Germany; Hospital Israelita Albert Einstein, São Paulo, Brazil; Department of Physiotherapy, OsloMet - Oslo Metropolitan University, Oslo, Norway. RB is supported by an Australian National Health and Medical Research Council Senior Principal Research Fellowship. NEF is an NIHR Senior Investigator and was supported through an NIHR Research Professorship (NIHR-RP-011-015). TS and PGC are supported by the NIHR Biomedical Research Centre, Oxford and the NIHR Leeds Biomedical Research Centre, respectively. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR, or the UK Department of Health. S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center, and Zuyderland Medical Center, Heerlen; M.J. Page, PhD, School of Public Health and Preventive Medicine, Monash University; S.L. Whittle, MBBS(Hons), MClinEpi, FRACP, Department of Rheumatology, The Queen Elizabeth Hospital and the University of Adelaide; H. Huang, MPH, Department of Orthopaedic Surgery, University of Michigan; A.P. Verhagen, MSc, PhD, University of Technology; D.E. Beaton, BScOT, PhD, Institute for Work & Health, Institute of Health Policy Management and Evaluation, and the University of Toronto; P. Richards, Patient Research Partner, University of Bristol; M. Voshaar, MSc, PhD Student, Department of Psychology, Health and Technology, University of Twente, and Patient Research Partner, OMERACT; B. Shea, PhD, Clinical Investigator and Adjunct Professor, Ottawa Hospital Research Institute, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; D.A. van der Windt, PhD, Professor of Primary Care Epidemiology, Arthritis Research UK Primary Care Centre, Institute for Primary Care and Health Sciences, Keele University; C. Kopkow, BScPT, MPH, PhD, Department of Applied Health Sciences, Hochschule für Gesundheit Bochum (University of Applied Sciences); M. Lenza, MD, PhD, Professor, Hospital Israelita Albert Einstein; N.B. Jain, MD, MSPH, Departments of Physical Medicine and Rehabilitation, Orthopaedics, and Epidemiology (Medicine), Vanderbilt University Medical Center; B. Richards, MBBS(Hons), MClinEpi, MSportsMed, FRACP, Royal Prince Alfred Hospital, Camperdown NSW, and University of Sydney; C. Hill, MBBS, MD, MSc, Department of Rheumatology, The Queen Elizabeth Hospital and the University of Adelaide; T.K. Gill, MBA, PhD, Adelaide Medical School, University of Adelaide; B. Koes, MSc, PhD, Department of General Practice, Erasmus University Medical Center; N.E. Foster, DPhil, BSc(Hons), FCSP, Arthritis Research UK Primary Care Centre, Research Institute for Primary Care and Health Sciences, Keele University; P.G. Conaghan, MBBS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; T. Smith, BSc (Hons), MSc, MA, PhD, MCSP, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; P. Malliaras, PhD, Monash Department of Physiotherapy, School of Primary and Allied Health Care, Monash University; Y. Roe, MSc, PhD, Department of Physiotherapy, OsloMet - Oslo Metropolitan University; J.J. Gagnier, ND, MSc, PhD, Department of Epidemiology, School of Public Health, Department of Orthopaedic Surgery, University of Michigan; R. Buchbinder, MBBS (Hons), MSc, PhD, FRACP, FAHMS, Monash Department of Clinical Epidemiology, Cabrini Institute, and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University. J.J. Gagnier and R. Buchbinder contributed equally to this work as senior authors. Address correspondence to Dr. S. Ramiro, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, 2300RC Leiden, the Netherlands. E-mail: Accepted for publication January 17, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181070DOI Listing
February 2019

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

J Rheumatol 2019 Feb 1. Epub 2019 Feb 1.

From the Institute for Work & Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto; Clinical Epidemiology Program, and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; Cardiovascular Research Methods Centre, University of Ottawa Heart Institute; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ontario, Canada; Department of Epidemiology and Biostatistics, and Department of Medical Humanities, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; Medicine Service, VA Medical Center; Department of Medicine, School of Medicine, University of Alabama; Division of Epidemiology, School of Public Health, University of Alabama, Birmingham, Alabama; SDG LLC, Cambridge, Massachusetts, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines; Sorbonne Université; Pitié Salpêtrière hospital, AP-HP, Rheumatology Department, Paris, France; Sydney Medical School, Institute of Bone and Joint Research and Department of Rheumatology, Royal North Shore Hospital, St. Leonards, Australia. PGC is funded in part by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. JAS is supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama. LMM is a Principal Investigator on the Australian Rheumatology Association Database, which has received arms-length funding from AbbVie Australia, Pfizer Australia, Janssen Australia, and Eli Lilly Australia. OMERACT is a registered nonprofit independent medical research organization whose goal is to improve and advance the health outcomes for patients with musculoskeletal conditions. OMERACT receives unrestricted educational grants from the American College of Rheumatology, the European League of Rheumatology, and several pharmaceutical companies. The grants are used to support fellows, international patient groups, and a major international biennial conference that results in many peer-reviewed publications. The views expressed in this article are those of the authors and do not necessarily reflect the position of the US Department of Veterans Affairs or the US government. D.E. Beaton, PhD, Senior Scientist, Institute for Work & Health, Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, and Associate Professor, Institute Health Policy, Management and Evaluation, University of Toronto; B.J. Shea, PhD, Senior Scientist, Ottawa Hospital Research Institute, Clinical Epidemiology Program, and School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa; L.J. Maxwell, PhD, Methodological Advisory to the Technical Advisory Group, OMERACT, University of Ottawa, and Centre for Practice- Changing Research, Ottawa Hospital Research Institute; G.A. Wells, MSc, PhD, Director, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, and Professor, Department of Epidemiology and Community Medicine, University of Ottawa; M. Boers, MD, PhD, Professor of Clinical Epidemiology, Amsterdam UMC, Vrije Universiteit Amsterdam; S. Grosskleg, BS, Secretariat, OMERACT, and University of Ottawa; C.O. Bingham III, MD, Professor of Medicine, Division of Rheumatology, Johns Hopkins University; P.G. Conaghan, MD, PhD, Director, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Deputy Director, NIHR Leeds Biomedical Research Centre; M.A. D'Agostino, MD, PhD, AP-HP, Hôpital Ambroise Paré, Rheumatology Department, and INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University; M.P. de Wit, PhD, OMERACT Patient Research Partner, and Amsterdam University Medical Centre, Department Medical Humanities, Amsterdam Public Health; L. Gossec, MD, PhD, Sorbonne Université, and AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; L.M. March, MBBS, PhD, Liggins Professor of Rheumatology and Musculoskeletal Epidemiology, Sydney Medical School, Institute of Bone and Joint Research, and Head of Department of Rheumatology, Royal North Shore Hospital; J.A. Singh, MBBS, MPH, Professor of Medicine and Epidemiology, Department of Medicine at the School of Medicine, University of Alabama at Birmingham; L.S. Simon, MD, Co-managing director of SDG LLC; V. Strand, MD, MACR, FACP, Biopharmaceutical Consultant; P. Tugwell, MD, MSc, Professor, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute. Address correspondence to D.E. Beaton, Senior Scientist, Institute for Work & Health, 481 University Ave., Toronto, Ontario M5G 2E9, Canada. E-mail: Accepted for publication January 24, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181218DOI Listing
February 2019

Utility of Magnetic Resonance Imaging in Diagnosis and Monitoring Enthesitis in Patients with Spondyloarthritis: An OMERACT Systematic Literature Review.

J Rheumatol 2019 Feb 1. Epub 2019 Feb 1.

From the Department of Clinical Immunology and Rheumatology, Christian Medical College; Cochrane South Asia, Christian Medical College, Vellore, India; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; Copenhagen Center for Arthritis Research (COPECARE), Copenhagen; Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, Glostrup, Denmark; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (BRC), Leeds Teaching Hospitals National Health Service (NHS) Trust; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Division of Medicine, University of New South Wales, Sydney, Australia. AJB and PGC are supported in part through the NIHR Leeds BRC. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR, or the UK Department of Health. A.J. Mathew, MBBS, DNB, DM, Associate Professor, Department of Clinical Immunology and Rheumatology, Christian Medical College, and PhD Fellow, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, and COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup; S. Krabbe, MD, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, and COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup; R. Kirubakaran, BSc, MSc, Biostatistician, Cochrane South Asia, Christian Medical College; A.J. Barr, MRCP, PhD, Consultant Rheumatologist and Honorary Senior Lecturer, NIHR Leeds BRC, Leeds Teaching Hospitals NHS Trust; P.G. Conaghan, MBBS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds BRC; P. Bird, B Med (Hons), FRACP, PhD, Grad Dip MRI, Associate Professor, Division of Medicine, University of New South Wales; M. Østergaard, MD, PhD, DMSc, Professor, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, and COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup. Address correspondence to A.J. Mathew, Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India, 632004. E-mail: Accepted for publication January 9, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181083DOI Listing
February 2019

The OMERACT MRI in Enthesitis Initiative: Definitions of Key Pathologies, Suggested MRI Sequences, and a Novel Heel Enthesitis Scoring System.

J Rheumatol 2019 Feb 1. Epub 2019 Feb 1.

From the Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark; Department of Diagnostic Imaging, Sheba Medical Center, Affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Hôpitaux Universitaires Pitié Salpêtrière; Paris 6 University, GRC-UPMC 08, Pierre Louis Institute of Epidemiology and Public Health; Service de Radiologie, Hôpital Lariboisière, AP-HP and Université Paris-Diderot, Paris, France; Division of Medicine, University of New South Wales, Sydney, Australia; Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; Department of Radiology and Diagnostic Imaging, and CaRE (Canadian Research Education) Arthritis and Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Radiology, Arthritis Imaging Research Group, University Hospital Charité, Berlin, Germany; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Faculty of Medicine and Health, University of Leeds, Leeds, UK. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health. A.J. Mathew, MBBS, DNB, DM, Associate Professor, Department of Clinical Immunology and Rheumatology, Christian Medical College, and PhD Fellow, Department of Clinical Medicine, Faculty of Health and Medical Sciences, COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, University of Copenhagen; S. Krabbe, MD, PhD Fellow, Department of Clinical Medicine, Faculty of Health and Medical Sciences, COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, University of Copenhagen; I. Eshed, MD, Professor, Department of Diagnostic Imaging, Sheba Medical Center, Affiliated to the Sackler School of Medicine, Tel Aviv University; F. Gandjbakhch, MD, Practicing Rheumatologist, Hôpitaux Universitaires Pitié Salpêtrière, Paris 6 University, GRC-UPMC 08, Pierre Louis Institute of Epidemiology and Public Health; P. Bird, B Med (Hons), FRACP, PhD, Grad Dip MRI, Associate Professor, University of New South Wales; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; M.S. Stoenoiu, MD, PhD, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain; V. Foltz, MD, Practising Rheumatologist, Hôpitaux Universitaires Pitié Salpêtrière; D. Glinatsi, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; R.G. Lambert, MB.BCh, FRCR, FRCPC, Professor, Department of Radiology and Diagnostic Imaging, University of Alberta; K.G. Hermann, MD, PhD, Senior Consultant, Department of Radiology, Arthritis Imaging Research Group, University Hospital Charité; W.P. Maksymowych MD, FRCP(C), Professor, Division of Rheumatology, Faculty of Medicine and Dentistry, University of Alberta; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; J.L. Jaremko, MD, PhD, FRCPC, Associate Professor, Department of Radiology, University of Alberta; R.P. Poggenborg, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; J. Paschke, BSc, CaRE (Canadian Research Education) Arthritis; J.D. Laredo, MD, Professor, Service de Radiologie, Hôpital Lariboisière, AP-HP and Université Paris-Diderot; P. Carron, MD, PhD, Department of Rheumatology, Ghent University Hospital; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service Trust; M. Østergaard, MD, PhD, DMSc, Professor, Department of Clinical Medicine, Faculty of Health and Medical Sciences, COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, University of Copenhagen. Address correspondence to Dr. M. Østergaard, COPECARE - Center for Rheumatology and Spine Diseases, Rigshospitalet, Nordre Ringvej 57, DK-2600 Glostrup, Denmark. E-mail: Accepted for publication January 9, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181093DOI Listing
February 2019

Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis Magnetic Resonance Imaging Score (OMERACT JAMRIS-SIJ).

J Rheumatol 2019 Feb 15. Epub 2019 Feb 15.

From the Institute of Medical Sciences, Faculty of Medicine, University of Toronto; Department of Diagnostic Imaging, The Hospital for Sick Children; Department of Translational Medicine, SickKids Research Institute, Peter Gilgan Center for Research and Learning; Dalla Lana School of Public Health, University of Toronto; Division of Rheumatology, The Hospital for Sick Children, University of Toronto; Department of Medical Imaging, University of Toronto; Department of Rheumatology, Center for Prognosis Studies in Rheumatologic Diseases, Toronto Western Hospital, Toronto, Ontario; Department of Rheumatology, University of Alberta; Department of Radiology and Diagnostic Imaging, University of Alberta; Division of Pediatric Rheumatology, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, UK; Department of Rheumatology, Leiden University Medical Center, Leiden; Reade | Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Children's Hospital of Philadelphia and Departments of Pediatric and Epidemiology, Philadelphia, Pennsylvania; Department of Radiology, Nemours Children's Hospital and Health System, Orlando, Florida, USA; Department of Radiology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland; Department of Radiology and Medical Imaging, Ghent University Hospital, Ghent, Belgium; Department of Radiology, Hospital Sant Joan de Deu, Barcelona, Spain; Department of Radiology, Rikshospitalet, Oslo University Hospital, Oslo, Norway; Pediatric Rheumatology Research Institute, Bad Bramstedt, Germany; Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India; State University of Campina-UNICAMP, Department of Internal Medicine, Cidade Universitaria, Sao Paulo, Brazil. P.G. Conaghan is funded in part by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the UK Department of Health. T.M. Otobo, MD, MSc, BMedSc, Institute of Medical Sciences, Faculty of Medicine, University of Toronto, and Department of Diagnostic Imaging, The Hospital for Sick Children, and Department of Translational Medicine, SickKids Research Institute, Peter Gilgan Center for Research and Learning; P.G. Conaghan, PhD, MB BS, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; W.P. Maksymowych, PhD, MB BS, FRACP, FRCP, Department of Rheumatology, University of Alberta; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P. Weiss, MD, MSCE, University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Children's Hospital of Philadelphia and Departments of Pediatric and Epidemiology; I. Sudol-Szopinska, MD, PhD, Department of Radiology, National Institute of Geriatrics, Rheumatology and Rehabilitation; N. Herregods, MD, PhD, Department of Radiology and Medical Imaging, Ghent University Hospital; J.L. Jaremko, MD, PhD, FRCPC, Department of Radiology and Diagnostic Imaging, University of Alberta; A.B. Meyers, MD, Department of Radiology, Nemours Children's Hospital and Health System; D. Rumsey, MD, FRCPC, Division of Pediatric Rheumatology, Department of Pediatrics, University of Alberta; E.C. Inarejos, MD, Department of Radiology, Hospital Sant Joan de Deu; E. Kirkhus, MD, PhD, Department of Radiology, Rikshospitalet, Oslo University Hospital; J. Stimec, MD, FRCPC, Department of Diagnostic Imaging, The Hospital for Sick Children; J. Panwar, MD, Department of Diagnostic Imaging, The Hospital for Sick Children; K. Thorpe, BMath, MMath, Dalla Lana School of Public Health, University of Toronto; L. Jans, MD, PhD, Department of Radiology and Medical Imaging, Ghent University Hospital; M.A. van Rossum, MD, PhD, Reade | Emma Children's Hospital/Academic Medical Center; M. Tolend, BSc, Institute of Medical Sciences, Faculty of Medicine, University of Toronto, and Department of Diagnostic Imaging, The Hospital for Sick Children, and Department of Translational Medicine, SickKids Research Institute, Peter Gilgan Center for Research and Learning; M. Perez, MD, Department of Diagnostic Imaging, The Hospital for Sick Children; N. Tzaribachev, MD, Pediatric Rheumatology Research Institute; P. Sandhya, MD, Department of Clinical Immunology and Rheumatology, Christian Medical College; S. Tse, MD, FRCPC, Division of Rheumatology, The Hospital for Sick Children, University of Toronto; A. Simone, MD, PhD, State University of Campina-UNICAMP, Department of Internal Medicine, Cidade Universitaria; V.G. Swami, MD, BSc, Department of Medical Imaging, University of Toronto; Z. Touma, MD, PhD, FACP, FACR, Department of Rheumatology, Center for Prognosis Studies in Rheumatologic Diseases, Toronto Western Hospital; R. Lambert, MB BCh, FRCR, FRCPC, Department of Radiology and Diagnostic Imaging, University of Alberta; A.S. Doria, MD, PhD, MSc, Institute of Medical Sciences, Faculty of Medicine, University of Toronto, and Department of Diagnostic Imaging, The Hospital for Sick Children, and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, and Department of Medical Imaging, University of Toronto. Address correspondence to Dr. A.S. Doria, Department of Diagnostic Imaging, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: Accepted for publication January 30, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181115DOI Listing
February 2019

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

J Rheumatol 2019 Feb 15. Epub 2019 Feb 15.

From the Centre for Practice-Changing Research, Ottawa Hospital Research Institute; Ottawa Hospital Research Institute, Clinical Epidemiology Program; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa; Cardiovascular Research Methods Centre, University of Ottawa Heart Institute; Department of Epidemiology and Community Medicine, University of Ottawa; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa; Institute for Work & Health; Institute Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Clinical Epidemiology, Amsterdam UMC, Vrije Universiteit Amsterdam; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health, Amsterdam, the Netherlands; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; Medicine and Epidemiology, Department of Medicine at the School of Medicine, University of Alabama, Birmingham, Alabama; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Rheumatology and Musculoskeletal Epidemiology, Sydney Medical School, Institute of Bone and Joint Research; Department of Rheumatology, Royal North Shore Hospital, St Leonards, Australia. PGC is funded in part by the NIHR Leeds Biomedical Research Centre. The views expressed in this article are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. JAS is supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama. LM is a Principal Investigator on the Australian Rheumatology Association Database, which has received arms-length funding from Pfizer Australia, AbbVie Australia, Eli Lilly Australia, and Janssen Australia. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the US Department of Veterans Affairs or the US government. L.J. Maxwell, PhD, University of Ottawa and Centre for Practice- Changing Research, Ottawa Hospital Research Institute; B.J. Shea, PhD, Clinical Investigator, Ottawa Hospital Research Institute, Clinical Epidemiology Program, and School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa; D.E. Beaton, PhD, Senior Scientist, Institute for Work & Health, and Associate Professor, Institute Health Policy, Management and Evaluation, University of Toronto; G.A. Wells, MSc, PhD, Director, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, and Professor, Department of Epidemiology and Community Medicine, University of Ottawa; M. Boers, MD, PhD, Professor of Clinical Epidemiology, Amsterdam UMC, Vrije Universiteit Amsterdam; S. Grosskleg, OMERACT Secretariat, University of Ottawa; C.O. Bingham III, MD, Division of Rheumatology, Department of Medicine, Johns Hopkins University; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre; M.A. D'Agostino, MD, PhD, AP-HP, Professor of Rheumatology, Hôpital Ambroise Paré, Rheumatology Department, and INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University; M. de Wit, PhD, OMERACT Patient Research Partner, and Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health; L. Gossec, MD, PhD, Professor of Rheumatology, Sorbonne Universités, UPMC Univ Paris 06, and AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; L. March, MBBS, PhD, Liggins Professor of Rheumatology and Musculoskeletal Epidemiology, Sydney Medical School, Institute of Bone and Joint Research and Department of Rheumatology, Royal North Shore Hospital; J.A. Singh, MBBS, MPH, Professor of Medicine and Epidemiology, Department of Medicine at the School of Medicine, University of Alabama; L.S. Simon, MD, Co- Managing Director of SDG LLC; V. Strand, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, MD, MSc, Professor, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute. Address correspondence to L.J. Maxwell, Centre for Practice-Changing Research, Ottawa Hospital General Campus, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada. E-mail: Accepted for publication December 19, 2018.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181097
Publisher Site
http://dx.doi.org/10.3899/jrheum.181097DOI Listing
February 2019

Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE).

J Rheumatol 2019 Feb 15. Epub 2019 Feb 15.

From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Diagnostic Imaging, Sheba Medical Center, Affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; University Pierre et Marie Curie - Paris 6, Sorbonne Universités, GRC-08 (EEMOIS); AP-HP, Rheumatology Department, Pitié Salpêtrière University Hospital, Paris, France; Division of Medicine, University of New South Wales, Sydney, Australia; Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India; Department of Radiology and Diagnostic Imaging, and Department of Medicine, University of Alberta; CaRE Arthritis, Edmonton, Canada; Department of Rheumatology, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels; Department of Radiology, Ghent University Hospital, Ghent, Belgium; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospital National Health Service (NHS) Trust, UK; Department of Radiology, Arthritis Imaging Research Group, University Hospital Charité, Berlin, Germany; Spire Sciences Inc., Boca Raton, Florida, USA. SK received research grants from The Danish Rheumatism Association and Rigshospitalet. PGC is supported in part by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the UK Department of Health. S. Krabbe, MD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; I. Eshed, MD, Department of Diagnostic Imaging, Sheba Medical Center, Affiliated to the Sackler School of Medicine, Tel Aviv University; F. Gandjbakhch, MD, University Pierre et Marie Curie - Paris 6, Sorbonne Universités, GRC-08 (EEMOIS), and AP-HP, Rheumatology Department, Pitié Salpêtrière University Hospital; S.J. Pedersen, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; P. Bird, MD, PhD, Division of Medicine, University of New South Wales; A.J. Mathew, MD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Clinical Immunology and Rheumatology, Christian Medical College; R.G. Lambert, MD, Department of Radiology and Diagnostic Imaging, University of Alberta; W.P. Maksymowych, MD, CaRE Arthritis, and Department of Medicine, University of Alberta; D. Glinatsi, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; M.S. Stoenoiu, MD, PhD, Department of Rheumatology, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain; R. Poggenborg, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; L. Jans, MD, PhD, Department of Radiology, Ghent University Hospital; J.L. Jaremko, MD, PhD, Department of Radiology and Diagnostic Imaging, University of Alberta; N. Herregods, MD, PhD, Department of Radiology, Ghent University Hospital; V. Foltz, MD, University Pierre et Marie Curie - Paris 6, Sorbonne Universités, GRC-08 (EEMOIS), and AP-HP, Rheumatology Department, Pitié Salpêtrière University Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospital NHS Trust; C.E. Althoff, MD, Department of Radiology, Arthritis Imaging Research Group, University Hospital Charité; J. Paschke, BSc, CaRE Arthritis; C. Peterfy, MD, PhD, Spire Sciences Inc.; K.A. Hermann, MD, PhD, Department of Radiology, Arthritis Imaging Research Group, University Hospital Charité; M. Østergaard, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen. Address correspondence to Dr. S. Krabbe, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Valdemar Hansens Vej 17, DK-2600 Glostrup, Denmark. E-mail: Accepted for publication January 24, 2019.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181084DOI Listing
February 2019

Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS).

J Rheumatol 2019 Feb 15. Epub 2019 Feb 15.

From the Department of Rheumatology, Diakonhjemmet Hospital; Institute of Health and Society, University of Oslo, Oslo, Norway; Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; Department of Clinical Medicine, University of Copenhagen, Copenhagen; King Christian 10th Hospital for Rheumatic Diseases; University of Southern Denmark, Institute of Regional Health Research, Graasten; Institute of Clinical Medicine, Aarhus University Hospital, Århus; Odense University Hospital; Institute of Clinical Research, University of Southern Denmark, Odense; Zealand University Hospital, Køge, Denmark; University of New South Wales, Sydney, Australia; Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK. U. Sundin, MD, Research Fellow, Department of Rheumatology, Diakonhjemmet Hospital, and Institute of Health and Society, University of Oslo; M. Østergaard, MD, PhD, DMSc, Professor, COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet, and the Department of Clinical Medicine, University of Copenhagen; D. Glinatsi, MD, PhD, Postdoctoral Researcher, COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet; A.B. Aga, MD, PhD, Senior Consultant and Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital Oslo; K. Hørslev-Petersen, MD, DMSc, Professor, Senior Consultant, King Christian 10th Hospital for Rheumatic Diseases, and the Institute of Regional Health Research, University of Southern Denmark; M.L. Hetland, MD, PhD, DMSc, Professor, COPECARE, Center for Rheumatology and Spine Diseases, Rigshospitalet, and the Department of Clinical Medicine, University of Copenhagen; K. Stengaard-Pedersen, MD, DMSc, Professor Emeritus, Institute of Clinical Medicine, Aarhus University Hospital; P. Junker, MD, DMSc, Professor, Department of Rheumatology, Odense University Hospital and Institute of Clinical Research, University of Southern Denmark; B.J. Ejbjerg, MD, PhD, Chief Consultant, Zealand University Hospital; P. Bird, BMed (Hons), FRACP, PhD, Grad Dip MRI, Associate Professor, University of New South Wales; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; S. Lillegraven, MD, MPH, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; E.A. Haavardsholm, MD, PhD, Professor, Department of Rheumatology, Diakonhjemmet Hospital, and Institute of Health and Society, University of Oslo. Address correspondence to Dr. U. Sundin, Diakonhjemmet Sykehus, Diakonveien 12, 0370 Oslo, Norway. E-mail: Accepted for publication December 6, 2018.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181064DOI Listing
February 2019

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

J Rheumatol 2019 Feb 15. Epub 2019 Feb 15.

From the Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit; Department of Medical Humanities, VU University Medical Centre/EMGO+ institute, Amsterdam, the Netherlands; Institute for Work & Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto; Centre for Practice-Changing Research, Ottawa Hospital Research Institute; Cardiovascular Research Methods Centre, University of Ottawa Heart Institute; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario; McGill Centre for Outcomes Research and Evaluation, Montreal, Quebec, Canada; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; Medicine Service, VA Medical Center; Department of Medicine, School of Medicine, University of Alabama; Division of Epidemiology, School of Public Health, University of Alabama, Birmingham, Alabama; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint- Quentin University, Saint-Quentin en Yvelines; Sorbonne Université; Pitié Salpêtrière hospital, AP-HP, Rheumatology Department, Paris, France; Sydney Medical School, Institute of Bone and Joint Research; Department of Rheumatology, Royal North Shore Hospital, St Leonards, Australia. DEB, COB III, PGC, MAD, MPD, LG, LM, LS, JAS, VS, GAW, and PT are members of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 12 companies. PGC is funded in part by the NIHR Leeds Biomedical Research Centre. The views expressed in this article are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. JAS is supported by the resources and use of the facilities at the VA Medical Center at Birmingham, Alabama, USA. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government. LM is a principal investigator on the Australian Rheumatology Association Database, which has received armslength funding from Pfizer Australia, AbbVie Australia, Eli Lilly Australia, and Janssen Australia. M. Boers, MD, PhD, Professor of Clinical Epidemiology, Amsterdam UMC, Vrije Universiteit Amsterdam; D.E. Beaton, PhD, Senior Scientist, Institute for Work & Health, and Associate Professor, Institute Health Policy, Management and Evaluation, University of Toronto; B.J. Shea, PhD, Senior Scientist, Ottawa Hospital Research Institute, Clinical Epidemiology Program, and School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; S.J. Bartlett, PhD, Professor of Medicine, McGill University, Centre for Outcomes Research and Evaluation, and Division of Rheumatology, Department of Medicine, Johns Hopkins University; C.O. Bingham III, MD, Division of Rheumatology, Department of Medicine, Johns Hopkins University; P.G. Conaghan, MBBS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; M.A. D'Agostino, MD, PhD, AP-HP, Professor of Rheumatology, Hôpital Ambroise Paré, Rheumatology Department, and INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University; M.P. de Wit, PhD, OMERACT Patient Research Partner, and Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health; L. Gossec, MD, PhD, Sorbonne Universités, UPMC Univ Paris 06, and AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; L. March, MBBS, PhD, Liggins Professor of Rheumatology and Musculoskeletal Epidemiology, Sydney Medical School, Institute of Bone and Joint Research, and Department of Rheumatology, Royal North Shore Hospital; J.A. Singh, MBBS, MPH, Professor of Medicine and Epidemiology, Department of Medicine at the School of Medicine, University of Alabama at Birmingham; L.S. Simon, MD, Co-Managing Director of SDG LLC; V. Strand, MD, Biopharmaceutical Consultant, Portola Valley, California, USA; G.A. Wells, MSc, PhD, Director, Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, and Professor, Department of Epidemiology and Community Medicine, University of Ottawa; P. Tugwell, MD, MSc, Professor, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute. Address correspondence to Dr. M. Boers, Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands. Accepted for publication December 6, 2018.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181096DOI Listing
February 2019

What Should Be the Primary Target of "Treat to Target" in Psoriatic Arthritis?

J Rheumatol 2019 Jan 15;46(1):38-42. Epub 2018 Sep 15.

From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio," Università degli Studi del Molise, Campobasso, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180267DOI Listing
January 2019

Update on magnetic resonance imaging and ultrasound in rheumatoid arthritis.

Clin Exp Rheumatol 2018 Sep-Oct;36 Suppl 114(5):16-23. Epub 2018 Oct 1.

Université Pierre et Marie Curie, Paris 6, Sorbonne Universités, GRC-08 (EEMOIS); APHP, Rheumatology Department, Pitié Salpêtrière University Hospital, Paris France.

View Article

Download full-text PDF

Source
January 2019

Update on imaging in rheumatic diseases.

Clin Exp Rheumatol 2018 Sep-Oct;36 Suppl 114(5). Epub 2018 Oct 1.

Division of Rheumatology, Rush University School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
January 2019

Patients' preferences for osteoarthritis treatment: the value of stated-preference studies.

Aging Clin Exp Res 2019 Jan 4;31(1):1-3. Epub 2019 Jan 4.

Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40520-018-1098-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390947PMC
January 2019

Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus.

Rheumatology (Oxford) 2019 Jan 3. Epub 2019 Jan 3.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/advance-article/doi/10
Publisher Site
http://dx.doi.org/10.1093/rheumatology/key422DOI Listing
January 2019

The SPECTRA Collaboration OMERACT Working Group: Criterion Validity of Joint Space Outcomes with High Resolution Peripheral Quantitative Computed Tomography.

J Rheumatol 2019 Jan 15. Epub 2019 Jan 15.

From the Department of Radiology, and Department of Medicine, McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary; Biomedical Engineering Graduate Program, Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Rheumatology and Clinical Immunology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Biomedical Engineering, The University of Melbourne, Parkville, Australia; Leeds Institute for Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK. The study was funded by The Arthritis Society. PGC is supported in part by the UK NIHR Leeds Biomedical Research Centre. S.L. Manske, PhD, Department of Radiology, McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, and Biomedical Engineering Graduate Program, Department of Radiology, Cumming School of Medicine, University of Calgary; S.C. Brunet, BSc, Department of Radiology, McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, and Biomedical Engineering Graduate Program, Department of Radiology, Cumming School of Medicine, University of Calgary; S. Finzel, MD, Department of Rheumatology and Clinical Immunology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg; K.S. Stok, PhD, Department of Biomedical Engineering, The University of Melbourne; P.G. Conaghan, MD, PhD, Leeds Institute for Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; S.K. Boyd, PhD, Department of Radiology, McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, and Biomedical Engineering Graduate Program, Department of Radiology, Cumming School of Medicine, University of Calgary; C. Barnabe, MSc, MD, Department of Medicine, McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary. Address correspondence to Dr. S.L. Manske, 3280 Hospital Dr NW, Calgary, Alberta T2N 4Z6, Canada. E-mail: Accepted for publication November 14, 2018.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180870
Publisher Site
http://dx.doi.org/10.3899/jrheum.180870DOI Listing
January 2019

Report from the Hand Osteoarthritis Working Group at OMERACT 2018: Update on Core Instrument Set Development.

J Rheumatol 2019 Jan 15. Epub 2019 Jan 15.

From the Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium; Department of Rheumatology, and Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; Division of Academic Rheumatology, University of Nottingham; National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; National Institute for Health Research (NIHR), Leeds Biomedical Research Centre, Leeds, UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Rheumatology, Sorbonne Université, INSERM, Saint-Antoine Hospital AP-HP, DHU i2B, Paris, France; Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA. PGC is supported in part by the UK NIHR Leeds Biomedical Research Centre. R. Wittoek, MD, PhD, Department of Rheumatology, Ghent University Hospital, Ghent University; F.P. Kroon, MD, Department of Rheumatology, Leiden University Medical Center; B. Kundakci, PT, MSc, Division of Academic Rheumatology, University of Nottingham; A. Abhishek, MD, MRCP, PhD, Division of Academic Rheumatology, University of Nottingham, and National Institute for Health Research, Nottingham Biomedical Research Centre; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; F. Berenbaum, MD, PhD, Department of Rheumatology, Sorbonne Université, INSERM, Saint-Antoine hospital AP-HP, DHU i2B; P.G. Conaghan MBBS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research, Leeds Biomedical Research Centre; M.L. Ishimori, MD, Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center; W. Smeets, Patient Representative, Department of Rheumatology, Leiden University Medical Center; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Kloppenburg, MD, PhD, Department of Rheumatology, and Department of Clinical Epidemiology, Leiden University Medical Center. Address correspondence to Dr. M. Kloppenburg, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, the Netherlands. E-mail: Accepted for publication November 14, 2018.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181003DOI Listing
January 2019

The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.

J Rheumatol 2019 Jan 15. Epub 2019 Jan 15.

From the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, and UK National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford; Institute of Translational Medicine, University of Liverpool, Liverpool; Faculty of Health and Medical Sciences, University of Surrey, Guildford; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, Faculty of Medicine, and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Institute of Bone and Joint Research, Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital; Inner West Psychology; School of Biological, Earth and Environmental Sciences, University of New South Wales, Sydney, Australia; Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers, location VUmc; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health, Amsterdam; Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands; Musculoskeletal Statistics Unit, the Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark; Université de Lorraine, Approches Épidémiologiques et Psychologiques (APEMAC), Nancy, France; Division of Rheumatology, Allergy and Immunology, Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina; Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Sections of Clinical Epidemiology and Rheumatology, Boston University School of Medicine, Boston, Massachusetts; TissueGene Inc., Rockville; Division of Rheumatology and Clinical Immunology, Department of Medicine and Division of Gerontology, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA; Merck Biopharma, Merck KGaA, Darmstadt; University Pain Centre, University Hospital Carl Gustav Carus, Dresden, Germany; Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania; Faculty of Humanities and Social Sciences, University of Lucerne, Lucerne, Switzerland. This research was supported by the NIHR Oxford Biomedical Research Centre (T.O. Smith) and the NIHR Leeds Biomedical Research Centre (Prof. Conaghan). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. T.O. Smith, PhD, Senior Researcher in Rehabilitation, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital; G.A. Hawker, PhD, Professor of Medicine, Department of Medicine, Faculty of Medicine, and Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto; D.J. Hunter, PhD, Florance and Cope Chair of Rheumatology, Chair of Institute of Bone and Joint Research, Professor of Medicine, Institute of Bone and Joint Research, Florance and Cope Professorial Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital; L.M. March, PhD, Liggins Professor of Rheumatology and Musculosketal Epidemiology Medicine, Institute of Bone and Joint Research, Florance and Cope Professorial Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital; M. Boers, PhD, Professor of Clinical Epidemiology, Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers; B.J. Shea, PhD, Adjunct Professor, Ottawa Hospital Research Institute; R. Christensen, PhD, Professor of Biostatistics and Clinical Epidemiology, Musculoskeletal Statistics Unit, the Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; F. Guillemin, PhD, Professor of Epidemiology and Public Health, Université de Lorraine, APEMAC; C.B. Terwee, PhD, Associate Professor in Clinimetrics, Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers, location VUmc; P.R. Williamson, PhD, Professor of Medical Statistics, Institute of Translational Medicine, University of Liverpool; S. Dodd, PhD, Lecturer in Biostatistics, Institute of Translational Medicine, University of Liverpool; E.M. Roos, PhD, Professor, Head of Research Unit, Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark; R.F. Loeser, MD, Herman and Louise Smith Distinguished Professor of Medicine, Division of Rheumatology, Allergy and Immunology, Thurston Arthritis Research Center, University of North Carolina; T.J. Schnitzer, PhD, Professor of Physical Medicine and Rehabilitation, Anesthesiology and Medicine (Rheumatology), Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine; M. Kloppenburg, PhD, Professor in Rheumatology, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Centre; T. Neogi, PhD, Professor, Sections of Clinical Epidemiology and Rheumatology, Boston University School of Medicine; C.H. Ladel, PhD, Clinical Biomarker and Diagnostics Lead, Merck Biopharma, Merck KGaA; G. Kalsi, MD, Chief Medical Officer, Senior Vice President of Clinical Development and Regulatory and Medical Affairs, TissueGene Inc.; U. Kaiser, PhD, Principal Investigator, University Pain Centre, University Hospital Carl Gustav Carus; T.W. Buttel, MA, Psychologist, Inner West Psychology, Sydney, Australia, and Institute of Bone and Joint Research, Florance and Cope Professorial Department of Rheumatology, School of Medicine, University of Sydney and Royal North Shore Hospital; A.E. Ashford, PhD, Emeritius Professor, School of Biological, Earth and Environmental Sciences, University of New South Wales; A. Mobasheri, DPhil, Professor of Musculoskeletal Physiology, Faculty of Health and Medical Sciences, University of Surrey, and Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine; N.K. Arden, MD, Professor in Rheumatic Diseases, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; A. Tennant, PhD, Permanent Visiting Professor, Faculty of Humanities and Social Sciences, University of Lucerne; M.C. Hochberg, MD, Professor of Medicine and Epidemiology and Public Health, Division of Rheumatology and Clinical Immunology, Department of Medicine and Division of Gerontology, Department of Epidemiology and Public Health, University of Maryland School of Medicine; M. de Wit, PhD, Visiting Fellow, Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health; P. Tugwell, PhD, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; P.G. Conaghan, PhD, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre. Address correspondence to Professor P.G. Conaghan, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS4 7SA, UK. E-mail: Requests can be made to the corresponding author for access to data relating to the work conducted. Accepted for publication December 3, 2018.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181194
Publisher Site
http://dx.doi.org/10.3899/jrheum.181194DOI Listing
January 2019

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

J Rheumatol 2019 Jan 15. Epub 2019 Jan 15.

From the Department of Family Medicine, and Department of Medicine, McGill University, Montreal, Quebec; Institute for Work & Health, Toronto; OMERACT; Ottawa Hospital Research Institute, Ottawa Hospital; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Division of Rheumatology, Hospital for Special Surgery; Department of Medicine, Weill Cornell Medical School, New York, New York; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona; Medicine Service, VA Medical Center; Department of Medicine, School of Medicine, University of Alabama at Birmingham; Division of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/ Rheumatology, Stanford University, Palo Alto, California; SDG LLC, Cambridge, Massachusetts, USA; Sydney Medical School, and Sydney School of Public Health, University of Sydney; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney; Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District; Department of Rheumatology, Royal North Shore Hospital, Reserve Road, St Leonards; Centre for Health Policy, School of Population and Global Health, The University of Melbourne, Melbourne; Discipline of Medicine, University of Adelaide; Rheumatology Unit, The Queen Elizabeth Hospital, Woodville; Department of Rheumatology, Royal Prince Alfred Hospital, Camperdown, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals National Health Service (NHS) Trust; NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, UK; Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Saint- Quentin en Yvelines, France; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health, Amsterdam, the Netherlands. The Parker Institute, Bispebjerg and Frederiksberg Hospital (RC) is supported by a core grant from the Oak Foundation (OCAY-13-309). PGC is supported in part by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. K.M. Andersen, MSc, Department of Family Medicine, McGill University, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; J.T. Cheah, MBBS, Rheumatology Fellow, Division of Rheumatology, Hospital for Special Surgery, and Fellow in Medicine, Department of Medicine, Weill Cornell Medicine; L. March, MBBS, MSc, PhD, FRACP, FAFPHM, Sydney Medical School, University of Sydney, and Institute of Bone and Joint Research, Kolling Institute, Northern Sydney Local Health District, and Department of Rheumatology, Royal North Shore Hospital; S.J. Bartlett, PhD, Professor, Department of Medicine, McGill University, and Adjunct Professor, Department of Medicine, Johns Hopkins University; D. Beaton, BscOT, PhD, Senior Scientist, Institute for Work & Health; C.O. Bingham III, MD, Division of Rheumatology, Department of Medicine, Johns Hopkins University; P.M. Brooks, MD, Centre for Health Policy, School of Population and Global Health, The University of Melbourne; R. Christensen, MSc, PhD, Professor of Biostatistics and Clinical Epidemiology, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, and Department of Rheumatology, Odense University Hospital; P.G. Conaghan, MBBS, PhD, Director, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Deputy Director, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust; M.A. D'Agostino, MD, PhD, APHP, Hôpital Ambroise Paré, Rheumatology Department, and INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil; M. de Wit, PhD, Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam Public Health; A. Dueck, PhD, Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic; S.M. Goodman, MD, Professor of Clinical Medicine, Division of Rheumatology, Hospital for Special Surgery, and Professor of Clinical Medicine, Department of Medicine, Weill Cornell Medical School; S. Grosskleg, OMERACT, and University of Ottawa; C.L. Hill, MBBS, MSc, MD, FRACP, Professor, Discipline of Medicine, University of Adelaide & Rheumatology Unit, The Queen Elizabeth Hospital; M. Howell, PhD, Sydney School of Public Health, The University of Sydney, and Centre for Kidney Research, The Children's Hospital at Westmead; S.L. Mackie, MB BCh, PhD, MRCP, Associate Clinical Professor, NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds; B. Richards, MBBS (Hons), MClinEpi, MSportsMed, FRACP, Department of Rheumatology, Royal Prince Alfred Hospital; B. Shea, PhD, Clinical Investigator, Ottawa Hospital Research Institute, Ottawa Hospital, and Adjunct Professor, Public Health, Faculty of Medicine, University of Ottawa; J.A. Singh, MBBS, MPH, Medicine Service, VA Medical Center, and Department of Medicine, School of Medicine, University of Alabama at Birmingham, and Division of Epidemiology, School of Public Health, University of Alabama at Birmingham; V. Strand, MD, Biopharmaceutical Consultant, Portola Valley, California, USA; P. Tugwell, MD, MSc, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; G.A. Wells, MSc, PhD, School of Epidemiology and Public Health, University of Ottawa, and Cardiovascular Research Methods Centre, University of Ottawa Heart Institute; L.S. Simon, MD, SDG LLC. Address correspondence to K.M. Andersen, Department of Family Medicine, McGill University, 5858 chemin de la Cote-des-Neiges, Montreal, Quebec H3S 1Z1, Canada. E-mail: Accepted for publication December 11, 2018.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181123DOI Listing
January 2019

Promoting self-management in older people with arthritis: Preliminary findings of the Northern Ireland Staying Connected Programme.

Musculoskeletal Care 2018 12 9;16(4):489-493. Epub 2018 Jul 9.

Leeds Institute of Rheumatic & Musculoskeletal Medicine & NIHR Leeds Biomedical Research Centre, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/msc.1353
Publisher Site
http://dx.doi.org/10.1002/msc.1353DOI Listing
December 2018

Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS).

J Rheumatol 2018 Dec 15. Epub 2018 Dec 15.

From the Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; Paris 6, Sorbonne Universités, GRC-08 (EEMOIS); AP-HP, Department of Rheumatology, Pitié Salpêtrière University Hospital, Paris, France; Spire Sciences Inc., Boca Raton, Florida; Data and Statistical Sciences, and Immunology Development, AbbVie Inc., North Chicago, Illinois; Departments of Radiology and Medicine, University of California at San Francisco, San Francisco, California; AbbVie Inc., Cambridge, Massachusetts, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health Research, Leeds Biomedical Research Centre, Leeds, UK; Department of Diagnostic Imaging, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. PGC is supported in part by the UK National Institute for Health Research infrastructure at Leeds. F.P. Kroon, MD, Department of Rheumatology, Leiden University Medical Center; S. van Beest, MD, Department of Rheumatology, Leiden University Medical Center; F. Gandjbakhch, MD, Practicing Rheumatologist, Paris 6, Sorbonne Universités, GRC-08 (EEMOIS), and AP-HP, Department of Rheumatology, Pitié Salpêtrière University Hospital; C.G. Peterfy, MD, PhD, FRCP, Chief Executive Officer, Spire Sciences Inc.; S. Chen, Data and Statistical Sciences, AbbVie Inc.; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Professor of Musculoskeletal Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health Research, Leeds Biomedical Research Centre; I. Eshed, MD, Associate Professor of Radiology, Department of Diagnostic Imaging, Sheba Medical Center, Tel Aviv University; V. Foltz, MD, Practicing Rheumatologist, Paris 6, Sorbonne Universités, GRC-08 (EEMOIS), and AP-HP, Department of Rheumatology, Pitié Salpêtrière University Hospital; H.K. Genant, MD, FACR, FRCR, Professor Emeritus of Radiology, Medicine and Orthopedics, Departments of Radiology and Medicine, University of California at San Francisco; I.K. Haugen, MD, PhD, Postdoctoral Researcher, Department of Rheumatology, Diakonhjemmet Hospital; J.K. Medema, MS, Senior Project Leader, Immunology Development, AbbVie Inc.; M. Østergaard, MD, PhD, DMSc, Professor of Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, and Department of Clinical Medicine, University of Copenhagen; L. Zhang, Data and Statistical Sciences, AbbVie Inc.; M.C. Levesque, MD, PhD, Foundational Immunology Senior Director, AbbVie Inc.; M. Kloppenburg, MD, PhD, Professor of Rheumatology, Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center. Address correspondence to Dr. F.P. Kroon, Department of Rheumatology, Leiden University Medical Center, Post Box 9600, 2300 RC Leiden, the Netherlands. E-mail: Accepted for publication November 7, 2018.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180949DOI Listing
December 2018

Patient-reported outcome measures in osteoarthritis: a systematic search and review of their use and psychometric properties.

RMD Open 2018 16;4(2):e000715. Epub 2018 Dec 16.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2018-000715DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307597PMC
December 2018

How to be NICEr in treating osteoarthritis.

Nat Rev Rheumatol 2018 Nov;14(11):625-626

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41584-018-0101-x
Publisher Site
http://dx.doi.org/10.1038/s41584-018-0101-xDOI Listing
November 2018

Remission in psoriatic arthritis-where are we now?

Rheumatology (Oxford) 2018 08;57(8):1321-1331

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex344DOI Listing
August 2018

What Imaging-Detected Pathologies Are Associated With Shoulder Symptoms and Their Persistence? A Systematic Literature Review.

Arthritis Care Res (Hoboken) 2018 Aug 6;70(8):1169-1184. Epub 2018 Jun 6.

University of Leeds, Leeds, and Arthritis Research UK Centre for Sport, Exercise, and Osteoarthritis, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099421PMC
August 2018

Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria.

Clin Exp Rheumatol 2018 Jan-Feb;36(1):115-120. Epub 2017 Sep 15.

Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, and the Leeds Trust Teaching Hospital, Chapel Allerton Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
April 2018

International patellofemoral osteoarthritis consortium: Consensus statement on the diagnosis, burden, outcome measures, prognosis, risk factors and treatment.

Semin Arthritis Rheum 2018 04 23;47(5):666-675. Epub 2017 Sep 23.

Department of General Practice, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands; Department of Orthopaedic Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2017.09.009DOI Listing
April 2018

Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial.

Arthritis Care Res (Hoboken) 2018 03 30;70(3):462-468. Epub 2018 Jan 30.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23293DOI Listing
March 2018

Novel joint selection methods can reduce sample size for rheumatoid arthritis clinical trials with ultrasound endpoints.

Int J Rheum Dis 2018 Mar 3;21(3):693-698. Epub 2017 Oct 3.

Department of Rheumatology and Immunology, Singapore General Hospital, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1756-185X.13185DOI Listing
March 2018

Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis: A Randomized Trial.

Ann Intern Med 2018 Mar 20;168(6):385-395. Epub 2018 Feb 20.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, United Kingdom (S.R.K., A.G., R.J.W., P.G.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M17-1430DOI Listing
March 2018

Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review.

Arthritis Care Res (Hoboken) 2018 01;70(1):39-52

University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23243DOI Listing
January 2018

The SPECTRA Collaboration OMERACT Special Interest Group: Current Research and Future Directions.

J Rheumatol 2017 Dec 1;44(12):1911-1915. Epub 2017 Aug 1.

From the Institute for Biomechanics, ETH Zurich, Zurich, Switzerland; Department of Biomedical Engineering, University of Melbourne, Melbourne, Victoria, Australia; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Departments of Medicine and Community Health Sciences, University of Calgary; McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161197DOI Listing
December 2017

Development and Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System.

J Rheumatol 2017 Nov 1;44(11):1694-1698. Epub 2017 Mar 1.

From the Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Rheumatology, Pitié Salpêtriere Hospital, APHP, Université Pierre et Marie Curie, Paris, France; Spire Sciences Inc., Boca Raton, Florida, USA; Department of Diagnostic Imaging, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Departments of Radiology and Medicine, University of California San Francisco, San Francisco, California, USA; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161099DOI Listing
November 2017

Is MRI a predictive biomarker for clinical response to biologics in rheumatoid arthritis?

Ann Rheum Dis 2017 11 10;76(11):e45. Epub 2017 Mar 10.

NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211265DOI Listing
November 2017

Development and Validation of the OMERACT Rheumatoid Arthritis Magnetic Resonance Tenosynovitis Scoring System in a Multireader Exercise.

J Rheumatol 2017 Nov 1;44(11):1688-1693. Epub 2017 May 1.

From the Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit; Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, UK; University of New South Wales (NSW), Sydney, Australia; Hôpital Pitié-Salpétrière, APHP, Université Paris VI, Paris, France; Diakonhjemmet Hospital, Oslo, Norway; Spire Sciences Inc., Boca Raton, Florida, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.161097
Publisher Site
http://dx.doi.org/10.3899/jrheum.161097DOI Listing
November 2017

Whole-body Magnetic Resonance Imaging in Inflammatory Arthritis: Systematic Literature Review and First Steps Toward Standardization and an OMERACT Scoring System.

J Rheumatol 2017 11 15;44(11):1699-1705. Epub 2017 Jun 15.

From the Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Diagnostic Imaging, The Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Arthritis Imaging Research Group, Department of Radiology, Charité Medical School, Berlin; Radiology, Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany; Department of Radiology and Diagnostic Imaging, and Division of Rheumatology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada; Spire Sciences Inc., Boca Raton, Florida, USA; St. James' University and Chapel Allerton Hospitals; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; University of New South Wales (NSW), Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161114DOI Listing
November 2017

The OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging (MRI) Scoring System: Updated Recommendations by the OMERACT MRI in Arthritis Working Group.

J Rheumatol 2017 Nov 15;44(11):1706-1712. Epub 2017 Aug 15.

From the Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; Department of Clinical Medicine, University of Copenhagen, Copenhagen; Slagelse Hospital, Slagelse, Denmark; Spire Sciences Inc., Boca Raton, Florida; Medicine and Orthopedics, University of California; Synarc Inc., San Francisco, California, USA; University of New South Wales (NSW), Sydney, Australia; Hôpital Pitié-Salpétrière, APHP, Université Paris VI, Paris, France; Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161433DOI Listing
November 2017

Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis.

Ann Rheum Dis 2017 Oct 12;76(10):1743-1746. Epub 2017 Jun 12.

School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211569DOI Listing
October 2017

The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.

Ann Rheum Dis 2017 Oct 12;76(10):1688-1692. Epub 2017 Jun 12.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2017-211137DOI Listing
October 2017

Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.

J Rheumatol 2017 Oct 1;44(10):1551-1559. Epub 2017 Aug 1.

From the Center for Medical Technology Policy; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Centre for Practice-Changing Research, Ottawa Hospital Research Institute; Ottawa Hospital Research Institute, Clinical Epidemiology Program; School of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa; Cardiovascular Research Methods Centre, University of Ottawa Heart Institute; Department of Epidemiology and Community Medicine, University of Ottawa; Department of Medicine, Faculty of Medicine, University of Ottawa; Cochrane Musculoskeletal, University of Ottawa, Ottawa; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital; Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne; Sydney Medical School, Institute of Bone and Joint Research and Department of Rheumatology, Royal North Shore Hospital, St. Leonards, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Montigny-le-Bretonneux; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medical Humanities, VU University Medical Centre/EMGO+ Institute, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161273DOI Listing
October 2017

Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review.

Evid Based Med 2017 10 2;22(5):170-177. Epub 2017 Sep 2.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ebmed-2017-110715DOI Listing
October 2017

Reducing arthritis pain through physical activity: a new public health, tiered approach.

Br J Gen Pract 2017 10;67(663):438-439

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3399/bjgp17X692633DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604795PMC
October 2017

The Relationship Between Synovial Pathobiology and Magnetic Resonance Imaging Abnormalities in Rheumatoid Arthritis: A Systematic Review.

J Rheumatol 2017 Sep 15;44(9):1311-1324. Epub 2017 Jul 15.

From the Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London; Department of Radiology, Barts Health UK National Health Service (NHS) Trust; Department of Rheumatology, Barts Health NHS Trust, London; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Centre, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.161314DOI Listing
September 2017

Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.

Clin Exp Rheumatol 2017 Jul-Aug;35(4):607-613. Epub 2017 Jan 27.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.

View Article

Download full-text PDF

Source
August 2017

Development and Reliability of a Preliminary Foot Osteoarthritis Magnetic Resonance Imaging Score.

J Rheumatol 2017 08 1;44(8):1257-1264. Epub 2017 Jun 1.

From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, and the School of Healthcare, University of Leeds; UK National Institute for Health Research (NIHR) Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds; Arthritis Research UK Experimental Osteoarthritis Treatment Centre, Leeds; Arthritis Research UK Centre for Sports, Exercise and Osteoarthritis, Nottingham/Leeds; Salford Royal Hospital UK National Health Service (NHS) Foundation Trust, Manchester, UK; Department of Musculoskeletal Radiology, La Paz University Hospital, Autonomous University of Madrid; Biomedical Research Networking Centre on Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160617DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544115PMC
August 2017

The effect of targeted treatment on people with patellofemoral pain: a pragmatic, randomised controlled feasibility study.

BMC Musculoskelet Disord 2017 Aug 4;18(1):338. Epub 2017 Aug 4.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Chapeltown Rd, Leeds, LS7 4SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-017-1698-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545020PMC
August 2017

Dichotomous versus semi-quantitative scoring of ultrasound joint inflammation in rheumatoid arthritis using novel individualized joint selection methods.

Clin Rheumatol 2017 May 3;36(5):1137-1141. Epub 2016 Oct 3.

Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-016-3432-5DOI Listing
May 2017

The contribution of musculoskeletal disorders in multimorbidity: Implications for practice and policy.

Best Pract Res Clin Rheumatol 2017 04 1;31(2):129-144. Epub 2017 Nov 1.

Arthritis Research UK, Copeman House, St Mary's Court, St Mary's Gate, Chesterfield S41 7TD, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.berh.2017.09.004DOI Listing
April 2017

Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis.

Ann Rheum Dis 2017 Mar 18;76(3):486-490. Epub 2016 Jul 18.

Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-209463DOI Listing
March 2017

Psoriatic arthritis: lessons from imaging studies and implications for therapy.

Expert Rev Clin Immunol 2017 Feb 10;13(2):133-142. Epub 2016 Aug 10.

b Leeds Institute of Rheumatic and Musculoskeletal Medicine , University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2016.1215245DOI Listing
February 2017

Synovitis in osteoarthritis: current understanding with therapeutic implications.

Arthritis Res Ther 2017 Feb 2;19(1):18. Epub 2017 Feb 2.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-017-1229-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289060PMC
February 2017

Ultrasound-detected pathologies cluster into groups with different clinical outcomes: data from 3000 community referrals for shoulder pain.

Arthritis Res Ther 2017 Feb 10;19(1):30. Epub 2017 Feb 10.

Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, 2nd Floor, Chapeltown Road, Leeds, LS7 4SA, UK.

View Article

Download full-text PDF

Source
http://arthritis-research.biomedcentral.com/articles/10.1186
Publisher Site
http://dx.doi.org/10.1186/s13075-017-1235-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304553PMC
February 2017

Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.

Rheumatology (Oxford) 2016 Dec 16;55(12):2181-2190. Epub 2016 Sep 16.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, School of Medicine, University of Leeds & NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew306DOI Listing
December 2016

Agreement between a physiotherapist and an orthopaedic surgeon regarding management and prescription of corticosteroid injection for patients with shoulder pain.

Man Ther 2016 Dec 5;26:216-222. Epub 2016 Oct 5.

Menzies Health Institute Queensland, Griffith University, Parklands Drive Southport, QLD 4222, Gold Coast, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.math.2016.10.001DOI Listing
December 2016

Bone Area Provides a Responsive Outcome Measure for Bone Changes in Short-term Knee Osteoarthritis Studies.

J Rheumatol 2016 12 1;43(12):2179-2182. Epub 2016 Oct 1.

From the Imorphics; Biomedical Imaging Institute, Manchester Academic Health Sciences Centre, University of Manchester, Manchester; Respiratory, Inflammation, Autoimmunity Innovative Medicines and Early Development (IMED), AstraZeneca, Cambridge; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia; Rheumatology Department, Royal North Shore Hospital, St. Leonards, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151118DOI Listing
December 2016

Improving joint pain and function in osteoarthritis.

Practitioner 2016 12;260(1799):17-20

View Article

Download full-text PDF

Source
December 2016

Knee Pain Predicts Subsequent Shoulder Pain and the Association Is Mediated by Leg Weakness: Longitudinal Observational Data from the Osteoarthritis Initiative.

J Rheumatol 2016 11 1;43(11):2049-2055. Epub 2016 Oct 1.

From the Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.160001
Publisher Site
http://dx.doi.org/10.3899/jrheum.160001DOI Listing
November 2016

Osteoarthritis.

Nat Rev Dis Primers 2016 10 13;2:16072. Epub 2016 Oct 13.

Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), 900 rue Saint-Denis, Suite R11.412, Montreal, Quebec H2X 0A9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2016.72DOI Listing
October 2016

Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations.

Pain 2016 Sep;157(9):1836-50

aCentre for Medical Education, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom bDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA cDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA dDepartment of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA eDepartment of Occupational Science and Occupational Therapy, University of Toronto, ON, Canada fInstitute for Work and Health, University of Toronto, ON, Canada gDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI, USA hInstitute for Work and Health, University of Toronto, ON, Canada iDepartment of Neurology, University of Rochester, Rochester, NY, USA jDepomed, Newark, CA, USA kLORAGroup LLC, Royal Oak, MD, USA lDepartment of Health Services Research University of Maryland, Baltimore, MD, USA mPublic Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA nDivision of Infection and Immunity, Cardiff University, Cardiff, Wales, United Kingdom oNIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom pInstitute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom qAmerican Chronic Pain Association, Rocklin, CA, USA rDepartment of Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA sDepartment of Neurology, Harvard University, Cambridge, MA, USA tDepartment of Anesthesiology, Queen's University, Ottawa, ON, Canada uDepartment of Psychiatry, Duke University Medical Center, Durham, NC, USA vPfizer, Inc, Durham, NC, USA wClinical and Rehabilitative Medicine Research Program, United States Army Medical Research and Materiel Command xPurdue Pharma L.P., Stamford, CT, USA yDepartment of Veterans Affairs, Veteran Affairs Connecticut Healthcare System, West Haven, CT, USA zDepartment of Psychiatry and Psychology, Yale University, New Haven, CT, USA aa

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/pain/2016/09000/Assessment_of_p
Web Search
http://dx.doi.org/10.1097/j.pain.0000000000000577DOI Listing
September 2016

The relationship between three-dimensional knee MRI bone shape and total knee replacement-a case control study: data from the Osteoarthritis Initiative.

Rheumatology (Oxford) 2016 09 15;55(9):1585-93. Epub 2016 May 15.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993955PMC
September 2016

Harmonising data collection from osteoarthritis studies to enable stratification: recommendations on core data collection from an Arthritis Research UK clinical studies group.

Rheumatology (Oxford) 2016 08 15;55(8):1394-402. Epub 2016 Apr 15.

Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis, University of Oxford MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957675PMC
August 2016

Imaging of osteoarthritis (OA): What is new?

Best Pract Res Clin Rheumatol 2016 08 12;30(4):653-669. Epub 2016 Oct 12.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216942163006
Publisher Site
http://dx.doi.org/10.1016/j.berh.2016.09.007DOI Listing
August 2016

The clinical characteristics of older people with chronic multiple-site joint pains and their utilisation of therapeutic interventions: data from a prospective cohort study.

BMC Musculoskelet Disord 2016 Apr 30;17:194. Epub 2016 Apr 30.

Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapeltown Rd, Leeds, LS7 4SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-016-1049-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853864PMC
April 2016